Effects of a clinical metagenomics intervention on clinical outcomes, healthcare costs, and health-related quality of life in patients with sepsis or septic shock: results of the randomized-controlled DigiSep trial - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Impact of a Metagenomics-Based Clinical Intervention on Patient Outcomes, Healthcare Expenses, and Quality of Life in Sepsis or Septic Shock: Findings from the Randomized-Controlled DigiSep Study

  • By

  • Thorsten Brenner

  • Annabell Skarabis

  • Stefan J. Schaller

  • Thilo von Groote

  • Christian Putensen

  • Ulf Günther

  • Martin Sauer

  • Sebastian O. Decker

  • Fabian Dusse

  • Manfred Weiss

  • Klaudiusz Suchodolski

  • Tim-Philipp Simon

  • Peter Rosenberger

  • Onnen Moerer

  • Matthias Unterberg

  • Jens-Christian Schewe

  • Hendrik Bracht

  • Selina Hutzl

  • Manuel Feißt

  • Ursula Marschall

  • Patrick Brandenburg

  • Philip Stevens

  • Juliana Schmidt

  • Mathias W. Pletz

  • Marc M. Berger

  • June 30, 2026

Share

Original Source(s)

Related Content